- Senior Investigator, Section for Translational Research on Retinal and Macular Degeneration
Paul Sieving received his M.D. from the University of Illinois in 1978 and trained in ophthalmology at that institution between 1978 and 1982. He earned a Ph.D. in bioengineering from the University of Illinois in 1981. He was a faculty member at the University of Michigan Medical School for 17 years and moved to NIH in 2001. He combines laboratory research with clinical patient studies of genetic retinal neurodegenerative diseases. He is a member of the Institute of Medicine and currently serves as director of the National Eye Institute.
- (2020). NEI-Supported Age-RelatedMacular Degeneration Research: Past, Present, and Future. Translational Vision Science & Technology. 9(7),
- (2020). "There Are Hills and Valleys": Experiences of Parenting a Son With X-Linked Retinoschisis. AMERICAN JOURNAL OF OPHTHALMOLOGY. 212, 98-104.
- (2020). Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. 36(1), 25-29.
- (2019). AAVrh-10 transduces outer retinal cells in rodents and rabbits following intravitreal administration. GENE THERAPY. 26(9), 386-398.